rediff.com
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (X) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23
Sales 3.18 10.88 18.89 24.64 20.16
Operating profit 0.81 4.43 9.54 5.09 0.34
Interest 0.06 0.07 0.07 0.06 0.08
Gross profit 1.46 5.74 10.04 5.27 0.89
EPS (Rs) 0.11 3.64 8.61 4.33 0.38
Quarterly  results in details
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23
Other income 0.72 1.38 0.56 0.24 0.63
Stock adjustment -0.90 -1.08 - 1.94 -0.16
Raw material 0.92 2.71 3.85 4.80 2.03
Power and fuel - - - - -
Employee expenses 1.38 1.58 1.35 1.37 1.34
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 0.97 3.25 4.15 11.44 16.61
Provisions made - - - - -
Depreciation 0.67 0.52 0.51 0.56 0.46
Taxation 0.31 1.24 0.11 -0.01 0.01
Net profit / loss 0.49 3.99 9.42 4.71 0.42
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 43.79 10.95 10.95 10.86 10.96
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 25.36 40.74 50.53 20.65 1.67
GPM (%) 37.52 46.82 51.62 21.16 4.26
NPM (%) 12.46 32.51 48.43 18.93 2.02
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close